Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Zavante is a clinicalstage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.
Founded
2015
Raised
$65M
Follow us
Alexa global traffic share
Acquired by
Nabriva Therapeutics
1
Latest funding Show all
$10,000,000
Debt financing - 2016
Square 1 Bank
$45,000,000
Venture capital (Series A) - 2016
Aisling Capital Frazier Healthcare Partners Longitude Capital
Acquisition
Xconomy

Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition

Health Strategy
$10,000,000 Debt financing
FinSMEs

Zavante Therapeutics Receives $10M Credit Facility from Square 1 Bank

Health Funding
$45,000,000 Venture capital (Series A)
VentureWire

The Daily Startup: Zavante Raises $45 Million to Treat Deadly Infections

Funding
$10,000,000 Venture capital
MedCity News

Zavante gets $10M for CRE-treating antibiotic to enter clinic